Skin Rashes Occur in Considerable Number of SARS-CoV-2 Cases
17 percent of SARS-CoV-2-positive cases reported skin rash as first presentation; 21 percent had skin rash as only clinical sign
Rates of Macrolide Resistance in S. pneumoniae High Across the U.S.
Clinicians should consider alternatives to macrolide monotherapy as empiric therapy for suspected community-acquired bacterial pneumonia
Meds for Enlarged Prostate Tied to Heart Failure Risk
Risk higher for men on alpha-blockers versus 5-alpha reductase inhibitors
Nasal Swab Test for COVID-19 Risky for Sinus Surgery Patients
Online information needed to warn those with history of sinus, pituitary surgery to avoid nasopharyngeal swab testing, use alternative testing
California Sues Country’s Largest Nursing Home Chain
Lawsuit claims nursing home company submitted false information to the ratings program
Opioid Maker Purdue Pharma Files Bankruptcy Plan
Plan remakes company into a new corporation with revenue targeted exclusively at reducing the nation's opioid crisis
Biden Administration Weighing National Face Mask Standards for Workplace
Temporary standard for face masks in the workplace would impact millions of workers and would likely last six months
Moderna Starts Testing COVID-19 Vaccine in Younger Children
Company also testing its vaccine in 3,000 older children, ages 12 to 17 years
Partial Pfizer COVID-19 Vaccination 63 Percent Effective
Estimated effectiveness 63 percent for period from more than 14 days after the first dose through seven days after the second dose
Mortality Increased in Association With SARS-CoV-2 U.K. Variant
Mortality hazard ratio was 1.64 in association with infection with VOC-202012/1 versus infection with previously circulating variants
